Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ALDR

Alder Biopharmaceuticals (ALDR) Stock Price, News & Analysis

Alder Biopharmaceuticals logo

About Alder Biopharmaceuticals Stock (NASDAQ:ALDR)

Advanced Chart

Key Stats

Today's Range
$18.88
$18.88
50-Day Range
$18.88
$18.88
52-Week Range
$8.39
$19.12
Volume
N/A
Average Volume
5.12 million shs
Market Capitalization
$1.58 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ALDR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Alder Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ALDR Stock News Headlines

Chase, Bank of America, Wells Fargo Preparing for BIG Change
Thanks to this brand-new law #S.1582 signed by President Trump… Jeff Brown believes the largest banks in America could soon begin to replace every single dollar in your bank account… With a better, more technologically advanced dollar… Potentially making a lot of people rich in the process.tc pixel
See More Headlines

ALDR Stock Analysis - Frequently Asked Questions

Alder Biopharmaceuticals Inc (NASDAQ:ALDR) announced its quarterly earnings data on Tuesday, August, 7th. The biopharmaceutical company reported ($1.04) earnings per share for the quarter, beating analysts' consensus estimates of ($1.05) by $0.01.

Based on aggregate information from My MarketBeat watchlists, some other companies that Alder Biopharmaceuticals investors own include Bristol Myers Squibb (BMY), (CPXX) (CPXX), NVIDIA (NVDA), Celldex Therapeutics (CLDX), Meta Platforms (META), Gilead Sciences (GILD) and Micron Technology (MU).

Company Calendar

Last Earnings
8/07/2018
Today
8/27/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:ALDR
CIK
1423824
Fax
N/A
Employees
202
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($4.87)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$296.43 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-226.13%
Return on Assets
-66.86%

Debt

Debt-to-Equity Ratio
1.74
Current Ratio
8.94
Quick Ratio
8.94

Sales & Book Value

Annual Sales
$1.62 million
Price / Sales
977.10
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.61 per share
Price / Book
11.73

Miscellaneous

Outstanding Shares
83,840,000
Free Float
N/A
Market Cap
$1.58 billion
Optionable
Optionable
Beta
2.64
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:ALDR) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners